Related Experiment Videos

Globular glial fibrillary acidic protein-reactive cytoplasmic inclusions in ependymoma: an immunoelectron-microscopic

J L Twiss1, L J Anderson, D S Horoupian

  • 1Department of Pathology (Neuropathology), Stanford University Medical Center, CA 94305.

Acta Neuropathologica
|January 1, 1993
PubMed

Insights

This study details a rare pediatric brain tumor, infratentorial ependymoma, in a young boy. Researchers identified unusual cytoplasmic inclusions in tumor cells, which were strongly positive for glial fibrillary acidic protein (GFAP).

Area of Science:

  • Neuro-oncology
  • Pediatric pathology
  • Cellular biology

Background:

  • Ependymomas are tumors arising from ependymal cells, often found in the posterior fossa (infratentorial) of children.
  • Recurrent pediatric brain tumors present significant treatment challenges.
  • Accurate histological classification is crucial for diagnosis and prognosis.

Observation:

  • A 27-month-old boy presented with recurrent infratentorial ependymoma.
  • Histological examination revealed neoplastic ependymal cells forming perivascular pseudo-rosettes.
  • A second cell population exhibited unique hyaline cytoplasmic inclusions, mimicking gemistocytic astrocytes.

Findings:

  • These cytoplasmic inclusions showed strong immunoreactivity for glial fibrillary acidic protein (GFAP).
  • Ultrastructural analysis described the inclusions as irregular, fenestrated bodies composed of electron-dense granular material.
  • Immunohistochemistry for ubiquitin and alpha B-crystallin was negative, differentiating them from Rosenthal fibers.
  • Immunoelectron microscopy confirmed these unusual, non-filamentous inclusions were diffusely GFAP positive.

Implications:

  • The presence of GFAP-positive cytoplasmic inclusions represents a novel histological feature in ependymoma.
  • This finding may refine diagnostic criteria and understanding of ependymoma cell differentiation.
  • Further research into the nature and origin of these inclusions could offer new therapeutic targets.

Related Concept Videos